Browse > Article
http://dx.doi.org/10.15230/SCSK.2020.46.4.349

Biotransformation of Ginsenoside Rd from Red Ginseng Saponin using Commercial β-glucanase  

Kang, Hye Jung (Department of Engineering Chemistry, Chungbuk National University, College of Engineering)
Lee, Jong Woo (Department of Engineering Chemistry, Chungbuk National University, College of Engineering)
Park, Tae Woo (Department of Engineering Chemistry, Chungbuk National University, College of Engineering)
Park, Hye Yoon (National Institute of Biological Resources)
Park, Junseong (Department of Engineering Chemistry, Chungbuk National University, College of Engineering)
Publication Information
Journal of the Society of Cosmetic Scientists of Korea / v.46, no.4, 2020 , pp. 349-360 More about this Journal
Abstract
Bio-conversion manufacturing technology has been developed to produce ginsenoside Rd which is increasingly in demand as a cosmetic material due to various possibilities related to improving skin function. In order to convert ginsenoside Rb1 which is contained in red ginseng saponin (RGS) into Rd, several commercial enzymes were tested. Viscoflow MG was found to be the most efficient. In order to optimize the conversion of RGS to ginsenoside Rd by enzymatic transition was carried out using response surface methodology (RSM) based on Box-Behnken design (BBD). The main independent variables were RGS concentration, enzyme concentration, and reaction time. Conversion of ginsenoside Rd was performed under 17 conditions selected according to BBD model and optimization conditions were analyzed. The concentration of the converted ginsenoside Rd ranged from 0.3113 g/L to 0.5277 g/L, and the highest production volume was obtained under condition of reacting 2% RGS and 1.25% enzyme for 13.5 hours. Consequently, RGS concentration, enzyme concentration which is 0.05 less than p-value and among the interactions between the independent variables, the interaction between enzyme concentration and reaction time was confirmed to be the most influential.
Keywords
red ginseng extract; ginsenoside Rd; bioconversion; ${\beta}$-glucanase; RSM;
Citations & Related Records
Times Cited By KSCI : 13  (Citation Analysis)
연도 인용수 순위
1 L. P. Christensen, Ginsenosides chemistry, biosynthesis, analysis, and potential health effects, Adv. Food Nutr. Res., 55, 1 (2009).   DOI
2 Y. S. Chang, E. K. Seo, C. Gyllenhaal and K. I. Block, Panax ginseng: A role in cancer therapy?, Integr. Cancer Ther., 2(1), 13 (2003).   DOI
3 C. H. Lee and J. H. Kim, A review on the medicinal potentials of ginseng and ginsenosides on cardiovascular diseases, J. Ginseng Res., 38(3), 161 (2014).   DOI
4 Z. T. Elma, E. Z. Ilian, and I. H. Christiana, Effect of ginsenoside Rg1 on insulin binding in mice liver and brain membranes, Phytotheraphy Res., 5(1), 46 (1991).   DOI
5 Y. Yokozawa and H. Oura, Facilitation of protein biosynthesis by ginsenoside-Rb2 administration in diabetic rats, J. Natural Products, 53(6), 1514 (1990).   DOI
6 D. H. Jeong, M. Irfan, S. D. Kim, S. Kim, J. H. Oh, C. K. Park, H. K. Kim and M. H. Rhee, Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation, J. Ginseng Res., 41(4), 548 (2017).   DOI
7 C. S. Lee, G. B. Nam and J. S. Park, Protopanaxatriol inhibits melanin synthesis through inactivation of the pCREB-MITF-tyrosinase signalling pathway in melanocytes, Clinical and Experimental Dermatology, 44(3), 295 (2019).   DOI
8 C. S. Lee, G. B. Nam, I. H. Bae and J. S. Park, Whitening efficacy of ginsenoside F1 through inhibition of melanin transfer in cocultured human melanocytesekeratinocytes and three dimensional human skin equivalent, J. Ginseng Res. 43(2), 300 (2019).   DOI
9 K. Y. Nam, The comparative understanding between red ginseng and white ginsengs process ginsengs (Panax ginseng C. A. Meyer), J. Ginseng Res. 29, 1 (2005).   DOI
10 D. H. Kim, J. H. Chung, J. S. Yoon, Y. M. Ha, S. Bae, E. K. Lee, K. J. Jung, M. S. Kim, Y. J. Kim, M. K. Kim and H. Y. Chung, Ginsenoside Rd inhibits the expressions of iNOS and COX-2 by suppressing NFkappaB in LPS-stimulated RAW264.7 cells and mouse liver, J. Ginseng Res. 37(1), 54 (2013).   DOI
11 W. K. Kim, S. Y. song, W. K. Oh, S. Kaewsuwan, T. L. Tien, W. S. Kim and J. H. Sung, Wound-healing effect of ginsenoside Rd from leaves of Panax ginseng via cyclic AMP-dependent protein kinase pathway, Eur. J. Pharmacol. 702(1-3), 285 (2013).   DOI
12 S. D. Ryu, M. G. Heo, and K. S. Yoon, Factors affecting physical properties of solid sunscreen using response surface methodology, J. Soc. Cosmet. Sci. Korea, 45(3), 237 (2019).   DOI
13 L. Zheng, J. J. Li, L. J. Gu, D. L. Zhang, Y. B. Wang and C. K. Sung, Ginsenosides Rb1 and Rd regulate proliferation of mature keratinocytes through induction of p63 expression in hair follicles, Phytother. Res. 27(7), 1095 (2013).   DOI
14 S. J. Kim and C. S. Park, Production of compound K using ginsenosides from ginseng leaf by commercial enzyme, Korean J. Food Preserv. 26(6), 703 (2019).   DOI
15 Y. Wang, K. D. Choi, H. Yu, F. Jin and W. T. Im, Production of ginsenoside F1 using commercial enzyme cellulase KN, J. Ginseng Res. 40(2), 121 (2016).   DOI
16 S. K. Kim, Y. S. Kwak, S. W. Kim, S. Y. Hwang, Y. S. Ko and C. M. Yoo, Improved method for the preparation of crude ginseng saponin. J. Ginseng Res., 22(3), 155 (1998).
17 E. J. Kim, Y. S. Yi, Y. J. Son, S. Y. Han, D. H. Kim, G. Nam, M. A. Hossain, J. H. Kim, J. S. Park and J. Y. Cho, BIOGF1K, a compound K-rich fraction of ginseng, plays an antiinflammatory role by targeting an activator protein-1 signaling pathway in RAW264.7 macrophage-like cells, J. Ginseng Res., 42(2), 233 (2018).   DOI